EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood type susceptibility to SARS-CoV-2 at a tertiary hospital in Accra, Ghana

Prince N Odoom, Olayinka S Okoh, Yaa Y Asare, Clara O Mac-Arthur, Judith D Azumah, Albert Mensah, Akua K Yalley, Kwamena W Sagoe, Nicholas I Nii-Trebi iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01108-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Prince N Odoom und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana. Hauptthemen laut MEDLINE: COVID-19, ABO Blood-Group System, SARS-CoV-2. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pandemics from viral outbreaks, such as that caused by SARS-CoV-2, have significant impacts worldwide. The factors that underlie differential susceptibility to severe COVID-19 outcomes are not fully understood. The role of the ABO blood group in the outcome of SARS-CoV-2 infections remains to be clarified in different populations. This study described the SARS-CoV-2 seroprevalence and examined the association of the ABO blood group with COVID-19 disease among apparently healthy and COVID-19 patients at the Korle Bu Teaching Hospital, Accra. The study involved 277 participants comprising 200 healthy individuals and 77 PCR-confirmed COVID-19 patients with mild or severe symptoms. Anti-SARS-CoV-2 antibody assay (IgM/IgG) was performed, and ABO blood grouping was done on plasma samples using the reverse blood grouping method. Statistical analyses were performed in R for the association of socio-demographic parameters and ABO blood groupings of participants with SARS-CoV-2 infection status. The total SARS-CoV-2 seropositivity was 61.4% (157/277). Most of the participants (245/277, 88.4%) were unvaccinated. Of the 245 unvaccinated individuals, 127 (51.8%) were IgG reactive. A significant association was observed between ABO blood group and COVID-19 disease status. Antigen A participants had a higher probability of symptomatic infection than non-antigen A individuals. Blood group O appeared more protective than other blood types among the participants. Seropositivity was high among the participants studied—vaccinated and unvaccinated. Blood group A is associated with an increased risk of COVID-19, whereas blood group O appears protective. Further studies involving larger sample sizes are required to confirm these findings. IMPORTANCE The transmissibility and virulence of SARS-CoV-2 and the severity of COVID-19 disease appeared to vary across nations and among populations. However, the factors that account for the differential susceptibility and COVID-19 outcomes are not well understood. The roles of host immune defense mechanisms and genetic makeup have been implicated. This study investigated the seroprevalence of anti-SARS-CoV-2 antibodies (IgM and IgG) in apparently healthy individuals and COVID-19 patients; using a reliable but inexpensive blood group typing based on direct hemagglutination technique and rigorous statistical analyses, we determined the association of ABO blood groups with COVID-19 disease. We found appreciably high seropositivity among the participants studied—both vaccinated and unvaccinated—and showed that blood type significantly influences SARS-CoV-2 infection and COVID-19 severity, with blood group A associated with severe COVID-19 disease, whereas blood group O appears protective. Further studies involving a larger sample size are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ABO Blood-Group SystemSARS-CoV-2HumansMaleGhanaFemaleAdultMiddle AgedAntibodies, ViralSeroepidemiologic StudiesTertiary Care CentersImmunoglobulin GAgedImmunoglobulin MYoung AdultDisease SusceptibilityAdolescent

Stichwörter der Autor:innen

COVID-19 susceptibilitySARS-CoV-2blood donorsblood groupingseroprevalence

Substanzen

ABO Blood-Group SystemAntibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana.
  • Department of Chemical Sciences, Anchor University, Lagos, Nigeria.
  • Anchor University Centre for Global Health, Lagos, Nigeria.
  • Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.
  • Holy Child Catholic Hospital, Sekondi-Takoradi, Ghana.

ORCID-Profile: Nicholas I Nii-Trebi

Zitieren

APA

Odoom, P. N., Okoh, O. S., Asare, Y. Y., Mac-Arthur, C. O., Azumah, J. D., Mensah, A., Yalley, A. K., Sagoe, K. W., & Nii-Trebi, N. I. (2025). Blood type susceptibility to SARS-CoV-2 at a tertiary hospital in Accra, Ghana. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01108-24

Vancouver

Odoom PN, Okoh OS, Asare YY, Mac-Arthur CO, Azumah JD, Mensah A, et al. Blood type susceptibility to SARS-CoV-2 at a tertiary hospital in Accra, Ghana. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01108-24

BibTeX
@article{Odoom2025,
  author = {Odoom, Prince N and Okoh, Olayinka S and Asare, Yaa Y and Mac-Arthur, Clara O and Azumah, Judith D and Mensah, Albert and Yalley, Akua K and Sagoe, Kwamena W and Nii-Trebi, Nicholas I},
  title = {Blood type susceptibility to SARS-CoV-2 at a tertiary hospital in Accra, Ghana},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01108-24}
}
Kostenlos starten →